Biological Therapy in Treating Patients With Metastatic Melanoma

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 1995

Study Completion Date

March 31, 2006

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL

aldesleukin

BIOLOGICAL

therapeutic tumor infiltrating lymphocytes

Trial Locations (1)

Fred Hutchinson Cancer Research Center, Seattle

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT00002786 - Biological Therapy in Treating Patients With Metastatic Melanoma | Biotech Hunter | Biotech Hunter